# Conditioned Placebo Effects and Treatment of Hypertension

> **NCT00269269** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- Hypertension

## Interventions

- **DRUG:** antihypertensive drug
- **BEHAVIORAL:** placebo

## Key facts

- **NCT ID:** NCT00269269
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** — (—)
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269269, "Conditioned Placebo Effects and Treatment of Hypertension". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00269269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*